With a proven track record of overseeing and conducting Phase 1 to 4 trials, Emmanuella Doh, M.D., excels in ensuring regulatory compliance while providing strategic leadership to cross-functional teams. Her proficiency in administering and training staff on a diverse array of psychiatric and cognitive scales underscores a steadfast commitment to achieving high data quality and study integrity. Driven by a dedication to advancing patient care through high-quality clinical research, Emmanuella Doh, M.D., has a notable ability to foster relationships with site staff and stakeholders, optimizing trial outcomes and enhancing collaborative efforts across the clinical research landscape.

 

As a Director of Clinical Research Operations, Emmanuella Doh, M.D., directed comprehensive clinical trial operations, which includes site selection, initiation, and monitoring, with an unwavering commitment to good clinical practice (GCP), International Conference on Harmonisation (ICH), and regulatory standards. She has successfully built and maintained strong relationships with key sponsors and investigative sites, promoting robust collaboration and site engagement. Emmanuella Doh, M.D., has also delivered extensive training on clinical assessments and psychometric scales, exemplifying a firm adherence to clinical protocols. Her expertise extends to driving patient recruitment strategies and closely monitoring site performance to surpass enrollment goals, demonstrating an exceptional ability to address challenges proactively.

 

Dr. Emmanuella Doh has served as the Director of Rater Training and Content Development at Winsantor Inc., where she developed and delivered comprehensive training sessions on clinical assessments, emphasizing the critical importance of primary endpoints. She provided medical review and approval for external resources and publications, ensuring alignment with established reporting standards. Additionally, Emmanuella Doh, M.D., oversaw activities related to data generation and clinical data review, all while engaging with investigators and site staff to ensure the highest quality of execution in study conduct. Her earlier tenure as a Clinical Research Monitor at ICON Clinical Research and as a Psychometric Rater/Sub-Investigator at Cenexel ACMR further solidified Her expertise in managing site activities and ensuring compliance with study protocols across various psychiatric trials, reinforcing Her pivotal role within the clinical research sphere.

 

Beyond clinical operations, Dr. Emmanuella Doh has made significant academic contributions through her research in neurology and psychiatry. She has authored and co-authored numerous articles published in both national and international peer-reviewed journals, providing valuable insights into psychiatric assessments, cognitive function, and clinical trial methodologies. 

 

Notably, one of her authored articles was the first of its kind in that therapeutic area to be conducted in Sub-Saharan Africa, marking a groundbreaking milestone in regional clinical research. Her research has been instrumental in shaping best practices within the field, influencing the development of innovative clinical protocols and psychometric evaluation techniques. Actively engaged in scientific discourse, she frequently collaborates with experts worldwide, contributing to groundbreaking studies that enhance patient care and treatment outcomes. With a strong emphasis on a holistic treating approach, Dr. Emmanuella Doh integrates comprehensive patient-centered methodologies, ensuring that research-driven interventions align with both physiological and psychological well-being to optimize therapeutic outcomes.

 

In addition to her extensive clinical research expertise, Dr. Emmanuella Doh is the Founder and CEO of Ease Insight Consultancy, LLC., a clinical research training and consulting firm established in 2023. Through this firm, she provides specialized training programs and strategic guidance to clinical research professionals, investigative sites, and organizations seeking to enhance their expertise in clinical trial conduct and regulatory compliance. Several clinical research sites have benefited from the firm’s tailored training programs, improving their operational efficiency, compliance with regulatory standards, and overall research quality. By leveraging her deep knowledge of site management, psychometric ratings, and clinical trial execution, Dr. Emmanuella Doh is committed to empowering the next generation of clinical researchers and improving the overall quality of clinical research practices globally.

 

Emmanuella Doh, M.D., holds a medical degree from the Faculty of Medicine & Biomedical Sciences in Cameroon and a Master of Public Health from Edinburgh Medical School, UK. Her skill set encompasses a deep knowledge of psychiatric rating scales, site management and monitoring, clinical trial design and execution, and a robust understanding of regulatory compliance. Bilingual in English and French, Emmanuella Doh, M.D., actively engages in scientific meetings to gather clinical insights and represents Her organization, further elevating Her contributions to the field of clinical research.